Iodine

keratin 20 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 15654538 [Monoclonal antibody therapy for malignant lymphoma]. 2005 Jan 15 3
2 14748653 Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma. 2004 Feb 1
3 15517123 [Monoclonal antibody treatment of malignant lymphoma]. 2004 Dec 1
4 15640794 Tositumomab and iodine [131I] tositumomab in the management of follicular lymphoma. An oncologist's view. 2004 Dec 1
5 12899647 Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab. 2003 2
6 12939722 Radioimmunotherapy for non-Hodgkin's lymphoma. 2003 Aug 1
7 11877757 Choosing an optimal radioimmunotherapy dose for clinical response. 2002 Feb 15 1
8 11877767 High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study. 2002 Feb 15 2
9 11960274 Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab). 2002 Mar 1
10 11049969 A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. 2000 Nov 1 1
11 11125287 [Immunotargeting of tumors: state of the art and prospects in 2000]. 2000 Nov 1
12 11701541 Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of Options. 2000 1
13 10561019 Radiolabeled antibody therapy of B-cell lymphomas. 1999 Oct 1
14 9779701 Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. 1998 Oct 1